Researchers have developed a peptide that targets a previously ‘undruggable’ protein implicated in more than 75% of human cancers and found that it slowed the proliferation of brain cancer cells in ...
When cancer-driving proteins resist various treatments, Northwestern University scientists have uncovered a new solution. Don't fight them—throw them in the cellular trash. In a new study published in ...
Meet MYC, the shapeless protein responsible for making the majority of human cancer cases worse. UC Riverside researchers have found a way to rein it in, offering hope for a new era of treatments. In ...
In a study published in Nature Communications, KI researchers have revealed a fascinating discovery that could be important in cancer treatments. This new insight involves c-MYC, a protein component ...
The MYC proteins (grey ribbons) bind to DNA and promote cancer progression. UCR researchers developed a molecule (orange pretzel-like shape) that binds to MYC, inhibiting its cancer-promoting function ...
Grove Biopharma, a private biotechnology company engineering protein-like polymers (PLPs) -- a new class of multifunctional biologics designed to address the most challenging intracellular drug ...
HYDRACs are a class of proteomimetic polymers designed to mark harmful proteins, like MYC and KRAS, for destruction rather than merely block their activity.
Hollow spheres made of MYC proteins open new doors in cancer research, scientists report. Hollow spheres made of MYC proteins open new doors in cancer research. Würzburg scientists have discovered ...
NTB bicyclic peptide library construction, MYC epitope screening, and chemical linearization of hit peptides followed by MS/MS sequencing. Credit: Journal of the American Chemical Society (2024). DOI: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results